Michael R. McMullen insider trades

Open-market stock purchases and sales by Michael R. McMullen, Director at Bristol Myers Squibb Co, from SEC Form 4 filings since Mar 26, 2010.

Recent trades

DateStockTradeValue
Sep 30, 2026BMY Bristol Myers Squibb CoBought (not open market)$35K
Jun 30, 2026BMY Bristol Myers Squibb CoBought (not open market)$35K
Mar 31, 2026BMY Bristol Myers Squibb CoBought (not open market)$35K
Feb 1, 2026BMY Bristol Myers Squibb CoBought (not open market)$220K
Dec 31, 2025BMY Bristol Myers Squibb CoBought (not open market)—
Nov 5, 2025KLAC KLA CorpBought (not open market)—

Companies traded

  • BMY Bristol Myers Squibb Co: other filings, last Sep 30, 2026
  • KLAC KLA Corp: other filings, last Nov 5, 2025
  • A Agilent Technologies, Inc: 59 sales, last Mar 8, 2024
  • COHR Coherent Inc: other filings, last Jul 1, 2022

Get free alerts when Michael R. McMullen files a new trade →